These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12504052)

  • 21. Perspective--Part II: radiotherapy for Graves Orbitopathy: the Columbia University experience.
    Kazim M
    Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):173-4. PubMed ID: 12021645
    [No Abstract]   [Full Text] [Related]  

  • 22. [Radiotherapy for Graves' ophthalmopathy].
    Kuhnt T; Müller AC; Janich M; Gerlach R; Hädecke J; Duncker GI; Dunst J
    Klin Monbl Augenheilkd; 2004 Nov; 221(11):915-21. PubMed ID: 15562354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiotherapy in the management of thyroid orbitopathy. Computed tomography and clinical outcomes.
    Kao SC; Kendler DL; Nugent RA; Adler JS; Rootman J
    Arch Ophthalmol; 1993 Jun; 111(6):819-23. PubMed ID: 8512483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endocrine orbitopathy: comparison of the long-term result and classification after radiotherapy].
    Seegenschmiedt MH; Keilholz L; Gusek-Schneider G; Barth S; Hensen J; Wolf F; Naumann GO; Sauer R
    Strahlenther Onkol; 1998 Sep; 174(9):449-56. PubMed ID: 9765685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypofractionated radiotherapy for Graves' orbitopathy.
    Heyd R; Strassmann G; Herkströter M; Martin T; Zamboglou N
    Rontgenpraxis; 2001; 54(3):94-100. PubMed ID: 11799870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy for thyroid orbitopathy. Effects on extraocular muscle balance.
    Wilson WB; Prochoda M
    Arch Ophthalmol; 1995 Nov; 113(11):1420-5. PubMed ID: 7487604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follow-up of extended pterional orbital decompression in severe Graves' ophthalmopathy.
    Korinth MC; Ince A; Banghard W; Gilsbach JM
    Acta Neurochir (Wien); 2002 Feb; 144(2):113-20; discussion 120. PubMed ID: 11862510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors in the radiotherapy of Graves' ophthalmopathy.
    Petersen IA; Kriss JP; McDougall IR; Donaldson SS
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):259-64. PubMed ID: 2118493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy.
    Erdei A; Steiber Z; Molnar C; Berenyi E; Nagy EV
    BMC Ophthalmol; 2018 Jan; 18(1):5. PubMed ID: 29329570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dosimetric analysis of radiotherapy with middle shielding blocks of different widths at the lower cervical supraclavicular field for stage N2-3 nasopharyngeal carcinoma].
    Li FM; Luo W; He ZC; Zhang L; Sun Y; Qin WJ; Lu LX; Han F; Liu XQ; Liu MZ
    Ai Zheng; 2007 Oct; 26(10):1127-32. PubMed ID: 17927886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change in proptosis following extraocular muscle surgery: effects of muscle recession in thyroid-associated orbitopathy.
    Gomi CF; Yang SW; Granet DB; Kikkawa DO; Langham KA; Banuelos LR; Levi L
    J AAPOS; 2007 Aug; 11(4):377-80. PubMed ID: 17409001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of different thyroid committed doses in radioiodine therapy for Graves' hyperthyroidism.
    Grosso M; Traino A; Boni G; Banti E; Della Porta M; Manca G; Volterrani D; Chiacchio S; AlSharif A; Borsò E; Raschillà R; Di Martino F; Mariani G
    Cancer Biother Radiopharm; 2005 Apr; 20(2):218-23. PubMed ID: 15869459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.
    Wakelkamp IM; Tan H; Saeed P; Schlingemann RO; Verbraak FD; Blank LE; Prummel MF; Wiersinga WM
    Ophthalmology; 2004 Aug; 111(8):1557-62. PubMed ID: 15288988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilateral inferior rectus muscle recession in patients with graves orbitopathy: is it effective?
    Jellema HM; Saeed P; Everhard-Halm Y; Prick L; Mourits M
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):268-72. PubMed ID: 22689133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between magnetic resonance imaging and ultrasound measurements of eye muscle thickness in thyroid-associated orbitopathy.
    Karhanova M; Kovar R; Frysak Z; Sin M; Zapletalova J; Rehak J; Herman M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):307-12. PubMed ID: 24510024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy.
    Baldeschi L; MacAndie K; Koetsier E; Blank LE; Wiersinga WM
    Am J Ophthalmol; 2008 Mar; 145(3):534-540. PubMed ID: 18191092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
    Juri J; Stiglmayer N; Kuzman T
    Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiographic analysis of extraocular muscle volumetric changes in thyroid-related orbitopathy following orbital decompression.
    Hu WD; Annunziata CC; Chokthaweesak W; Korn BS; Levi L; Granet DB; Kikkawa DO
    Ophthalmic Plast Reconstr Surg; 2010; 26(1):1-6. PubMed ID: 20090474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
    Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H
    Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial.
    Rajendram R; Taylor PN; Wilson VJ; Harris N; Morris OC; Tomlinson M; Yarrow S; Garrott H; Herbert HM; Dick AD; Cook A; Gattamaneni R; Jain R; Olver J; Hurel SJ; Bremner F; Drummond SR; Kemp E; Ritchie DM; Rumsey N; Morris D; Lane C; Palaniappan N; Li C; Pell J; Hills R; Ezra DG; Potts MJ; Jackson S; Rose GE; Plowman N; Bunce C; Uddin JM; Lee RWJ; Dayan CM
    Lancet Diabetes Endocrinol; 2018 Apr; 6(4):299-309. PubMed ID: 29396245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.